Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Neogenomics Inc. (NASDAQ: NEO) closed the day trading at $14.16 up 5.51% from the previous closing price of $13.42. In other words, the price has increased by $5.51 from its previous closing price. On the day, 0.85 million shares were traded. NEO stock price reached its highest trading level at $14.47 during the session, while it also had its lowest trading level at $13.4.
Ratios:
For a better understanding of NEO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.95 and its Current Ratio is at 6.20. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 29, 2023, Reiterated its Buy rating but revised its target price to $21 from $25 previously.
On August 21, 2023, Stephens Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’24 when TETRAULT LYNN A. sold 6,112 shares for $15.97 per share. The transaction valued at 97,579 led to the insider holds 50,062 shares of the business.
Olivo Alicia C sold 2,587 shares of NEO for $38,713 on Feb 15 ’24. The General Counsel now owns 34,866 shares after completing the transaction at $14.96 per share. On Nov 17 ’23, another insider, Olivo Alicia C, who serves as the General Counsel of the company, sold 2,669 shares for $18.39 each. As a result, the insider received 49,083 and left with 37,140 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 1807750528 and an Enterprise Value of 1909002752. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.06 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 3.227 whereas that against EBITDA is -82.409.
Stock Price History:
Over the past 52 weeks, NEO has reached a high of $21.22, while it has fallen to a 52-week low of $11.03. The 50-Day Moving Average of the stock is -6.05%, while the 200-Day Moving Average is calculated to be -8.44%.
Shares Statistics:
Over the past 3-months, NEO traded about 904.46K shares per day on average, while over the past 10 days, NEO traded about 704390 shares per day. A total of 127.37M shares are outstanding, with a floating share count of 126.18M. Insiders hold about 1.16% of the company’s shares, while institutions hold 99.20% stake in the company. Shares short for NEO as of 1711584000 were 7236813 with a Short Ratio of 8.00, compared to 1709164800 on 7013308. Therefore, it implies a Short% of Shares Outstanding of 7236813 and a Short% of Float of 7.88.
